We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about ductal breast cancer, the most common type. Understand its types (DCIS and IDC), symptoms, risk factors, diagnosis, and treatment options available.

What is Ductal Breast Cancer? Ductal breast cancer is the most common type of breast cancer, originating in the milk ducts. It encompasses two main forms: Ductal Carcinoma In Situ (DCIS) and Invasive Ductal Carcinoma (IDC). Understanding these types, their symptoms, and available treatments is crucial for early detection and effective management. Breast cancer, in general, is a significant health concern, with approximately 297,790 people in the United States expected to receive a diagnosis in 2023. Lifetime statistics indicate that about 13% of women will be diagnosed with breast cancer. While primarily affecting cisgender women, it's important to remember that individuals assigned male at birth can also develop breast cancer, with ductal breast cancer being a common form in such cases. Types of Ductal Breast Cancer Ductal breast cancer is broadly categorized into two main types: Ductal Carcinoma In Situ (DCIS): Often referred to as Stage 0 breast cancer, DCIS is a non-invasive form. This means the abnormal cells are confined to the milk ducts and have not yet spread into the surrounding breast tissue. While not considered invasive, DCIS has the potential to develop into invasive ductal carcinoma if left untreated. It is characterized by abnormal cells within the ducts, but without invasion into other tissues. Invasive Ductal Carcinoma (IDC): This is the most common type of breast cancer, accounting for about 70-80% of all breast cancer diagnoses. In IDC, the cancer cells begin in the milk ducts but then break through the duct walls and invade the surrounding breast tissue. From there, they can potentially spread to the lymph nodes and other parts of the body (metastasize). Risk Factors for Ductal Breast Cancer Several factors can increase an individual's risk of developing ductal breast cancer: Age: The risk increases with age. Reproductive History: Starting menstruation before age 12, experiencing menopause after age 55, never having a full-term pregnancy, or having the first pregnancy at an older age are associated with higher risk. Genetics: Mutations in certain genes, such as BRCA1 and BRCA2, significantly increase the likelihood of developing breast cancer. Family History: Having a close relative with breast cancer can increase your risk. Personal History: A previous diagnosis of breast cancer or certain non-cancerous breast conditions can raise the risk of developing it again. Lifestyle Factors: Obesity, lack of physical activity, excessive alcohol consumption, and smoking can also contribute to increased risk. Symptoms of Ductal Breast Cancer It is crucial to note that many individuals, especially those with DCIS, may not experience any noticeable symptoms. This underscores the importance of regular screening. However, potential symptoms can include: A new lump or thickening in the breast or underarm area. Changes in nipple size or shape. Nipple discharge that is not breast milk (e.g., bloody or clear). Changes in the skin of the breast, such as dimpling, puckering, redness, or scaling (sometimes described as 'peau d'orange' or orange peel-like skin). Inverted nipples. It's important to remember that most breast changes or symptoms are not caused by cancer. However, any unusual or persistent changes should be evaluated by a healthcare professional. Diagnosis of Ductal Breast Cancer Diagnosing ductal breast cancer typically involves a combination of methods: Physical Examination: A doctor will examine your breasts and underarm area for any lumps or other abnormalities. Mammogram: This is a specialized X-ray of the breast used to detect abnormalities that may not be felt. It is a primary screening tool. Other Imaging Tests: If a mammogram shows something suspicious, further imaging such as an ultrasound or MRI may be recommended to get a clearer picture. Biopsy: This is the definitive diagnostic procedure. A small sample of breast tissue is removed and examined under a microscope to determine if cancer cells are present and to identify the type and grade of cancer. Staging of Ductal Breast Cancer The stage of breast cancer helps determine the extent of the disease and guides treatment decisions. Staging is based on factors like tumor size, lymph node involvement, and whether the cancer has spread to distant parts of the body. Stage 0: Ductal Carcinoma In Situ (DCIS) – abnormal cells are present but have not spread. Stage 1: Invasive cancer, with a small tumor (2 cm or less) and no spread to lymph nodes. Stage 2: The tumor is larger (2-5 cm) and may have spread to nearby lymph nodes, or it is larger than 5 cm but has not spread to lymph nodes. Stage 3: The cancer has spread more extensively into nearby tissues and lymph nodes but has not metastasized to distant organs. Stage 4: Metastatic breast cancer, where the cancer has spread to distant parts of the body, such as the bones, lungs, liver, or brain. The grade of the cancer (how abnormal the cells look and how quickly they are dividing) is also an important factor. High-grade DCIS (nuclear grade 3) or DCIS with a high mitotic rate indicates a higher likelihood of recurrence. Treatment Options for Ductal Breast Cancer Treatment for ductal breast cancer is tailored to the individual, considering the type of cancer (DCIS or IDC), stage, grade, hormone receptor status, HER2 status, and the patient's overall health. Common treatment modalities include: Surgery: This may involve lumpectomy (removing the tumor and a margin of healthy tissue) or mastectomy (removal of the entire breast). Lymph nodes may also be removed or biopsied. Radiation Therapy: High-energy rays are used to kill cancer cells, often after
In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026